Juge-Morineau N - Search Results

1

Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy.

Puthier D, Pellat-Deceunynck C, Barillé S, Robillard N, Rapp MJ, Juge-Morineau N, Harousseau JL, Bataille R, Amiot M. Puthier D, et al. Leukemia. 1999 Feb;13(2):289-94. doi: 10.1038/sj.leu.2401302. Leukemia. 1999. PMID: 10025904 Clinical Trial.

2

Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells.

Pellat-Deceunynck C, Bataille R, Robillard N, Harousseau JL, Rapp MJ, Juge-Morineau N, Wijdenes J, Amiot M. Pellat-Deceunynck C, et al. Blood. 1994 Oct 15;84(8):2597-603. Blood. 1994. PMID: 7522634 Free article.

3

The retinoblastoma susceptibility gene RB-1 in multiple myeloma.

Juge-Morineau N, Harousseau JL, Amiot M, Bataille R. Juge-Morineau N, et al. Leuk Lymphoma. 1997 Jan;24(3-4):229-37. doi: 10.3109/10428199709039011. Leuk Lymphoma. 1997. PMID: 9156653 Review.

4

The gp 130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells.

Juge-Morineau N, François S, Puthier D, Godard A, Bataille R, Amiot M. Juge-Morineau N, et al. Br J Haematol. 1995 Jul;90(3):707-10. doi: 10.1111/j.1365-2141.1995.tb05605.x. Br J Haematol. 1995. PMID: 7647014

5

High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells.

Juge-Morineau N, Mellerin MP, Francois S, Rapp MJ, Harousseau JL, Amiot M, Bataille R. Juge-Morineau N, et al. Br J Haematol. 1995 Nov;91(3):664-7. doi: 10.1111/j.1365-2141.1995.tb05365.x. Br J Haematol. 1995. PMID: 8555072

6

[Role of glucocorticoids in the treatment of multiple myeloma].

Juge-Morineau N, Harousseau JL, Bataille R. Juge-Morineau N, et al. Ann Med Interne (Paris). 1996;147(8):576-9. Ann Med Interne (Paris). 1996. PMID: 9137685 Review. French.

7

Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma.

Moreau P, Milpied N, Mahé B, Juge-Morineau N, Rapp MJ, Bataille R, Harousseau JL. Moreau P, et al. Among authors: juge morineau n. Bone Marrow Transplant. 1999 May;23(10):1003-6. doi: 10.1038/sj.bmt.1701763. Bone Marrow Transplant. 1999. PMID: 10373065

8

Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.

Chevallier P, Roland V, Mahé B, Juge-Morineau N, Dubruille V, Guillaume T, Vigouroux S, Moreau P, Milpied N, Garand R, Avet-Loiseau H, Harousseau JL. Chevallier P, et al. Among authors: juge morineau n. Leuk Res. 2005 Sep;29(9):1003-7. doi: 10.1016/j.leukres.2005.02.005. Epub 2005 Apr 8. Leuk Res. 2005. PMID: 16038726

9

Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study.

Moreau P, Milpied N, Voillat L, Colombat P, Mahé B, Rapp MJ, Moreau A, Dupas B, Bulabois CE, Juge-Morineau N, Harousseau JL. Moreau P, et al. Bone Marrow Transplant. 1998 Jun;21(12):1193-6. doi: 10.1038/sj.bmt.1701272. Bone Marrow Transplant. 1998. PMID: 9674850

10

Immunoglobulins D and M multiple myeloma variants are heavily mutated.

Juge-Morineau N, Heirman C, Bakkus M, Van Camp B, Malfait R, Harousseau JL, Thielemans K, Bataille R. Juge-Morineau N, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2501-6. Clin Cancer Res. 1997. PMID: 9815653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters